A new therapy for advanced neuroendocrine tumors (NETs) shows promising outcomes in a first-in-human study. Lutathera-177 (177Lu)-DOTATATE (trade name from Latest Drug News https://ift.tt/2tB97Mg
No comments
Thanks for comment via will connect you within 24 hours.